TP53 and acute myeloid leukemia: Consistent with the prolonged simvastatin effect as shown in the washout experiments, simvastatin pretreatment of AML cells before co-incubation with CAR T-cells led to a complete rescue of the specific killing of both TP53-mutant MOLM13 and MV4-11 AML cells (Fig. 6D,E).